Clinical Trial Update: Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1 [NA]

View source ↗

Summary

A trial (Trial #1) is evaluating tools to communicate scleroderma research results to patients, sponsored by the Lady Davis Institute. The study is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Lady Davis Institute | Conditions: Scleroderma, Systemic Sclerosis | NA | Status: NOT_YET_RECRUITING